Stay updated with breaking news from Jay Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.
<p>Flu season is upon us, and existing vaccines are only ~40-60% effective at reducing the risk of serious illness. The <a href="https://www.childrenshospital.org/research/departments/pediatrics-research/precision-vaccines-program">Precision Vaccines Program</a> (PVP) at Boston Children’s Hospital was awarded a Vaccine Adjuvant Development Program contract (75N93023C00040) from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) that can extend up to 5 years and $9 million, to develop a small molec...
MISSOULA – The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for
MISSOULA – The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for
The National Institutes of Health awarded a $12.3 million contract to the University of motnana to develop a novel vaccine.The National Institutes of Health rec